OncoSec Blog OncoSec to Present at the 21st Annual H.C. Wainwright Global Investment Conference

SAN DIEGO and PENNINGTON, N.J., Sept. 6, 2019 /PRNewswire/ - OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer of OncoSec, will present a company overview at the 21st Annual H.C. Wainwright Global Investment Conference on Monday, September 9, 2019, at [...]